#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15218	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2457	763.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1892	1892	T	973	T,G,C,A	970,1,1,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	15218	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2457	763.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1626	1626	C	1004	C	1002	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26090	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4044	805.1	0	.	n	.	0	T695C	SNP	695	695	T	1213	1213	C	1023	C,T,G	1017,3,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26090	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4044	805.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2489	2489	C	948	C	947	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26090	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4044	805.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2563	2563	A	897	A,G	896,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26090	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4044	805.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3115	3115	C	921	C,A	920,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2224	folP	855	855	100.0	folP.l15.c4.ctg.1	2023	137.4	1	SNP	p	R229S	0	.	.	685	687	CGC	1252	1254	CGC	229;231;232	C;G;C	229;231;232	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3909	165.6	1	SNP	p	S91F	0	.	.	271	273	TCC	778	780	TCC	172;174;175	T;C;C	172;174;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3909	165.6	1	SNP	p	D95G	0	.	.	283	285	GAC	790	792	GAC	179;178;178	G;A,C;C	179;177,1;178	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5184	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3909	165.6	1	SNP	p	D95N	0	.	.	283	285	GAC	790	792	GAC	179;178;178	G;A,C;C	179;177,1;178	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1948	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1677	144.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	784	786	AAT	232;233;235	A;A;T	232;233;235	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1948	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1677	144.6	1	SNP	p	G45D	0	.	.	133	135	GGC	682	684	GGC	231;232;233	G;G;C	231;232;233	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1124	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1400	100.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1680	1682	ATC	278;278;279	A;T;C	278;278;279	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1833	1835	GCA	274;276;277	G;C;A,T,G	274;276;275,1,1	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	1	SNP	p	D86N	0	.	.	256	258	GAC	786	788	GAC	250;251;249	G;A;C	250;251;249	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	1	SNP	p	S87R	0	.	.	259	261	AGT	789	791	AGT	249;249;248	A,T,C,G;G;T	246,1,1,1;249;248	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	1	SNP	p	S87I	0	.	.	259	261	AGT	789	791	AGT	249;249;248	A,T,C,G;G;T	246,1,1,1;249;248	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	1	SNP	p	S87W	0	.	.	259	261	AGT	789	791	AGT	249;249;248	A,T,C,G;G;T	246,1,1,1;249;248	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	5572	parC	2304	2304	99.7	parC.l6.c30.ctg.1	3453	201.4	1	SNP	p	S88P	0	.	.	262	264	TCC	792	794	TCC	247;246;246	T;C;C	247;246;246	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4226	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3172	166.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1845	1847	GGC	254;251;251	G;G;C	254;251;251	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1460	1462	GCA	267;266;264	G;C,A;A	267;265,1;264	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1463	1465	ATC	264;263;268	A;T;C	264;263;268	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1475	1477	GTG	265;272;275	G,C;T,G;G,C	264,1;271,1;274,1	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1475	1477	GTG	265;272;275	G,C;T,G;G,C	264,1;271,1;274,1	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1979	1981	ACC	223;223;223	A;C;C,T,A	223;223;221,1,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2033	2035	GCG	238;242;243	G,T;C;G,A	237,1;242;242,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2033	2035	GCG	238;242;243	G,T;C;G,A	237,1;242;242,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2156	2158	GGT	248;247;247	G;G,A,T;T	248;245,1,1;247	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2165	2167	GGC	255;256;260	G;G;C	255;256;260	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4288	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2838	188.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2183	2185	CCG	259;260;261	C,T,A;C,A;G	257,1,1;258,2;261	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5762	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3657	196.9	0	.	p	.	0	P553S	NONSYN	1657	1659	CCG	2345	2347	TCG	245;249;251	T,C,A;C,T;G	243,1,1;248,1;251	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5762	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	3657	196.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1949	1951	CTG	252;253;254	C;T,A;G,C	252;252,1;253,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2578	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2308	139.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	766	766	C	204	C	204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	D41K	NONSYN	121	123	GAC	583	585	AAA	257;256;256	A;A,C;A	257;255,1;256	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	889	891	CAA	256;257;256	C;A;A	256;257;256	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1096	1098	GAT	256;259;258	G;A,C;T	256;258,1;258	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	H213N	NONSYN	637	639	CAT	1099	1101	AAT	256;257;260	A;A;T,G	256;257;259,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	V215D	NONSYN	643	645	GTT	1105	1107	GAT	268;266;268	G,C,T;A;T	266,1,1;266;268	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1114	1116	ATG	272;277;276	A;T,C;G,T	272;276,1;275,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1231	1233	AAG	254;250;247	A;A,G;G	254;249,1;247	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3032	porB1b	1047	1047	98.28	porB1b.l15.c17.ctg.1	1843	202.6	1	SNP	p	G120K	0	.	.	358	360	GGC	820	822	GGC	256;256;255	G;G;C,A	256;256;254,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10354	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5244	246.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1502	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	1411	132.4	1	SNP	p	V57M	0	.	.	169	171	GTG	758	760	GTG	270;267;268	G;T;G	270;267;268	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
